![Special Report: Financial Firms Project Rapid Growth of Genetic Testing Market through 2030](https://www.g2intelligence.com/wp-content/uploads/2023/07/July23.LIR_.GeneticTestingBizTrends-iStock-1302573302-1100x800-1-1080x675.jpg)
Special Report: Financial Firms Project Rapid Growth of Genetic Testing Market through 2030
The outlook of the global genetic testing market based on recent reports from five financial consulting firms.
The outlook of the global genetic testing market based on recent reports from five financial consulting firms.
After an eventful month in the Illumina-GRAIL saga, the story may soon be over.
Recent developments pose reimbursement and compliance challenges for billing and coding infectious disease testing—here’s how to manage them.
The national retailer recently signed a deal with Simple HealthKit to provide Walmart customers online access to at-home diagnostic test kits.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
While ChatGPT has its place, allowing lab staff to use it exposes you to liabilities—here are some ways to manage the risks involved.
As generative AI chatbot use increases, labs may want to implement a written acceptable use policy for staff.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.